Chun-Hong Shen

Chun-Hong Shen

Auto-generated profile, based on publicly available information

Chun-Hong Shen

Department of Neurology Epilepsy Center, Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Clinical Immunology
Verified
Journal Article
Closed access
ELEr-Chuang Li
Er-Chuang Li
QLQi-Lun Lai
Qi-Lun Lai
MCMeng-Ting Cai
Meng-Ting Cai
YZYang Zheng
Yang Zheng
GFGao-Li Fang
Gao-Li Fang
YZYin-Xi Zhang
Yin-Xi Zhang

1 March 2025 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
ELEr-Chuang Li
Er-Chuang Li
TZTian-Yi Zhang
Tian-Yi Zhang
MCMeng-Ting Cai
Meng-Ting Cai
SSSheng-Yao Su
Sheng-Yao Su
CSChun-Hong Shen
Chun-Hong Shen
YZYin-Xi Zhang
Yin-Xi Zhang
In dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, DPPX antibodies from serum and CSF target the extracellular subunit of the voltage-gated potassium channel 4.2. This targeting leads to a characteristic clinical triad comprising gastrointestinal symptoms (predominantly diarrhea), cognitive-psychiatric dysfunction, and manifestations of CNS hyperexcitability, with hyperekplexia being a more specific feature. This rare disease typically presents with a subacute or chronic course and often affects middle-aged and older individuals. Patients may have a weak association with certain hematologic malignancies, particularly lymphoma and chronic lymphocytic leukemia. Brain MRI typically shows normal findings or nonspecific white matter changes. DPPX antibody-associated encephalitis responds well to immunotherapy, and most patients ultimately present with a good prognosis. However, relapses can occur. To improve our understanding of this rare but treatable autoimmune encephalitis and avoid misdiagnosis, we conduct a systematic review and summarize the current knowledge of its clinical and paraclinical features, management, and prognosis.

25 January 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
QLQi-Lun Lai
Qi-Lun Lai
MCMeng-Ting Cai
Meng-Ting Cai
ELEr-Chuang Li
Er-Chuang Li
GFGao-Li Fang
Gao-Li Fang
CSChun-Hong Shen
Chun-Hong Shen
YZYin-Xi Zhang
Yin-Xi Zhang
Background Neuronal surface antibody-associated autoimmune encephalitis (NSAE) is a group of neuro-inflammatory disorders that is mediated by autoantibodies against the cell-surface and synaptic antigens. Studies have explored the role of neurofilament light chain (NfL) in NSAE and provided inconsistent data. We performed a systematic review and meta-analysis to evaluate the NfL levels in the serum and cerebrospinal fluid (CSF) of patients with NSAE. Methods The National Center for Biotechnology Information (NCBI, PubMed), Web of Knowledge, and the Cochrane Library databases were searched for studies reporting NfL levels in patients with NSAE. Random-effects meta-analysis was used to pool results across studies. Results Thirteen studies were included in the final systematic review and meta-analysis. The serum NfL levels were significantly higher in patients with NSAE compared to unaffected controls (standardized mean difference [SMD] = 0.909, 95% confidence interval [CI]: 0.536–1.282). Similarly, the CSF NfL levels were elevated in patients with NSAE (SMD = 0.897, 95% CI: 0.508–1.286). The serum and CSF NfL levels were not significantly correlated with disease severity, prognosis, and abnormalities in magnetic resonance imaging, electroencephalography, and CSF. Conclusions NfL levels in the serum and CSF were higher in patients with NSAE compared to unaffected controls. However, the NfL levels were not shown to be significantly associated with clinical or paraclinical features.

12 February 2026 in Epilepsia
Verified
Journal Article
Closed access
HSHao Song
Hao Song
BDBing‐Qing Du
Bing‐Qing Du
YGYi Ge
Yi Ge
YCYi‐He Chen
Yi‐He Chen
SGShi‐Yu Geng
Shi‐Yu Geng
CSChun‐Hong Shen
Chun‐Hong Shen

27 June 2025 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ZWZhong-Jin Wang
Zhong-Jin Wang
WMWen-Jie Ming
Wen-Jie Ming
FLFang Li
Fang Li
SWShuang Wang
Shuang Wang
CSChun-Hong Shen
Chun-Hong Shen

1 May 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
HSHao Song
Hao Song
SXSha Xu
Sha Xu
BDBing-Qing Du
Bing-Qing Du
QLQi-Lun Lai
Qi-Lun Lai
MCMeng-Ting Cai
Meng-Ting Cai
CSChun-Hong Shen
Chun-Hong Shen
Purpose: Autoimmune limbic encephalitis (ALE) often occurs with detectable neuronal antibodies, presenting with seizures as a prominent clinical manifestation. We aimed to investigate the clinical characteristics and seizure outcomes in a cohort with antibody-positive ALE. Methods: We consecutively recruited patients with antibody-positive ALE and new-onset seizures between July 2014 and February 2024. Their demographic, clinical, and paraclinical characteristics, and treatment were collected. Seizure outcomes during follow-up were evaluated respectively, as well as the associated risk factors. Results: Seventy-two patients were included, and the associated autoantibodies targeted the leucine-rich glioma-inactivated 1 (LGI1), gamma-aminobutyric acid type B receptor (GABABR), and glutamic acid decarboxylase 65 (GAD65). Secondarily generalized tonic-clonic seizures and focal non-motor seizures were the most prevalent seizure semiologies, and 28 (38.9%) patients exhibited multiple seizure types. Furthermore, among 54 patients with over two years of follow-up, 16 (29.6%) experienced intermittent seizures lasting for more than one year. Younger onset, specific antibodies, and multiple seizure types were correlated with the longer seizure duration (all P < 0.05). Six (11.1%) patients continued to have seizures even after two years of follow-up, comprising two with LGI1 and four with GAD65 antibodies. Female sex, younger onset, and specific antibody profiles were significantly associated with sustained seizures, indicating autoimmune-associated epilepsy (AAE, all P < 0.05). Conclusion: In patients with antibody-positive ALE, seizure outcomes appeared to change over an extended follow-up period, particularly in those with LGI1 and GABABR antibodies. Younger age at disease onset, female sex, and specific antibody profiles may be indicators of AAE.